283 related articles for article (PubMed ID: 32189076)
1. Alleviating pain with delta opioid receptor agonists: evidence from experimental models.
Berthiaume S; Abdallah K; Blais V; Gendron L
J Neural Transm (Vienna); 2020 Apr; 127(4):661-672. PubMed ID: 32189076
[TBL] [Abstract][Full Text] [Related]
2. Aiming at Ideal Therapeutics-MOPr/DOPr or MOPr-DOPr Heteromertargeting Ligand.
Fujita W
Curr Top Med Chem; 2020; 20(31):2843-2851. PubMed ID: 32324516
[TBL] [Abstract][Full Text] [Related]
3. The Delta Opioid Receptor in Pain Control.
Abdallah K; Gendron L
Handb Exp Pharmacol; 2018; 247():147-177. PubMed ID: 28510066
[TBL] [Abstract][Full Text] [Related]
4. Ligand-specific recycling profiles determine distinct potential for chronic analgesic tolerance of delta-opioid receptor (DOPr) agonists.
Bagheri Tudashki H; Haddad Y; Charfi I; Couture R; Pineyro G
J Cell Mol Med; 2020 May; 24(10):5718-5730. PubMed ID: 32279433
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitor-induced emergence of synaptic δ-opioid receptors and behavioral antinociception in persistent neuropathic pain.
Tao W; Zhou W; Wang Y; Sun T; Wang H; Zhang Z; Jin Y
Neuroscience; 2016 Dec; 339():54-63. PubMed ID: 27646288
[TBL] [Abstract][Full Text] [Related]
6. Delta-opioid receptors as targets for migraine therapy.
Charles A; Pradhan AA
Curr Opin Neurol; 2016 Jun; 29(3):314-9. PubMed ID: 27023737
[TBL] [Abstract][Full Text] [Related]
7. Spinal activation of delta opioid receptors alleviates cancer-related bone pain.
Otis V; Sarret P; Gendron L
Neuroscience; 2011 Jun; 183():221-9. PubMed ID: 21458544
[TBL] [Abstract][Full Text] [Related]
8. LP1 and LP2: Dual-Target MOPr/DOPr Ligands as Drug Candidates for Persistent Pain Relief.
Pasquinucci L; Parenti C; Georgoussi Z; Reina L; Tomarchio E; Turnaturi R
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299443
[TBL] [Abstract][Full Text] [Related]
9. Molecular Pharmacology of δ-Opioid Receptors.
Gendron L; Cahill CM; von Zastrow M; Schiller PW; Pineyro G
Pharmacol Rev; 2016 Jul; 68(3):631-700. PubMed ID: 27343248
[TBL] [Abstract][Full Text] [Related]
10. Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia.
Dripps IJ; Bertels Z; Moye LS; Tipton AF; Siegersma K; Baca SM; Kieffer BL; Pradhan AA
Sci Rep; 2020 Oct; 10(1):17629. PubMed ID: 33077757
[TBL] [Abstract][Full Text] [Related]
11. The multitarget opioid ligand LP1's effects in persistent pain and in primary cell neuronal cultures.
Parenti C; Turnaturi R; Aricò G; Gramowski-Voss A; Schroeder OH; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Ronsisvalle G; Pasquinucci L
Neuropharmacology; 2013 Aug; 71():70-82. PubMed ID: 23541722
[TBL] [Abstract][Full Text] [Related]
12. Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.
Beaudry H; Gendron L; Morón JA
Eur J Neurosci; 2015 Apr; 41(7):901--7. PubMed ID: 25639561
[TBL] [Abstract][Full Text] [Related]
13. Differential barcoding of opioid receptors trafficking.
Degrandmaison J; Grisé O; Parent JL; Gendron L
J Neurosci Res; 2022 Jan; 100(1):99-128. PubMed ID: 34559903
[TBL] [Abstract][Full Text] [Related]
14. A Novel G Protein-Biased Agonist at the
Conibear AE; Asghar J; Hill R; Henderson G; Borbely E; Tekus V; Helyes Z; Palandri J; Bailey C; Starke I; von Mentzer B; Kendall D; Kelly E
J Pharmacol Exp Ther; 2020 Feb; 372(2):224-236. PubMed ID: 31594792
[TBL] [Abstract][Full Text] [Related]
15. Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesics.
Ananthan S
AAPS J; 2006 Mar; 8(1):E118-25. PubMed ID: 16584118
[TBL] [Abstract][Full Text] [Related]
16. TRPV1 promotes opioid analgesia during inflammation.
Basso L; Aboushousha R; Fan CY; Iftinca M; Melo H; Flynn R; Agosti F; Hollenberg MD; Thompson R; Bourinet E; Trang T; Altier C
Sci Signal; 2019 Apr; 12(575):. PubMed ID: 30940767
[TBL] [Abstract][Full Text] [Related]
17. Endosomal signaling of delta opioid receptors is an endogenous mechanism and therapeutic target for relief from inflammatory pain.
Jimenez-Vargas NN; Gong J; Wisdom MJ; Jensen DD; Latorre R; Hegron A; Teng S; DiCello JJ; Rajasekhar P; Veldhuis NA; Carbone SE; Yu Y; Lopez-Lopez C; Jaramillo-Polanco J; Canals M; Reed DE; Lomax AE; Schmidt BL; Leong KW; Vanner SJ; Halls ML; Bunnett NW; Poole DP
Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15281-15292. PubMed ID: 32546520
[TBL] [Abstract][Full Text] [Related]
18. [Pain inhibition by opioids-new concepts].
Stein C
Anaesthesist; 2019 Feb; 68(2):97-103. PubMed ID: 30645691
[TBL] [Abstract][Full Text] [Related]
19. Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease.
Parker KE; Sugiarto E; Taylor AMW; Pradhan AA; Al-Hasani R
Mol Pharmacol; 2020 Oct; 98(4):433-444. PubMed ID: 32958571
[TBL] [Abstract][Full Text] [Related]
20. A new tridecapeptide with an octaarginine vector has analgesic therapeutic potential and prevents morphine-induced tolerance.
Kashkin VA; Shekunova EV; Titov MI; Eliseev II; Gureev MA; Porozov YB; Makarova MN; Makarov VG
Peptides; 2018 Jan; 99():61-69. PubMed ID: 29175519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
